Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2016	Jan. 31, 2015
Income Statement [Abstract]
Revenue
Operating Expenses
Depreciation and Amortization of Property and Equipment	$ 1,379	$ 1,986
Amortization of Patent Application Costs	2,211	2,379
General and Administrative	138,346	133,611
Research and Product Development	59,160	67,720
Total operating expenses	201,096	205,696
Operating Loss	(201,096)	(205,696)
Other Expenses (Income)
Interest Expense and Bank Charges, net	126,176	159,115
Loss (Gain) on Change in Value of Derivative Liability	(54,634)	652,348
Loss (Gain) on Foreign Exchange Transactions	(147,346)	43,671
Total Other Expenses (Income)	(75,804)	(855,134)
Net Loss	$ (125,292)	$ (1,060,830)
Basic and Diluted Net Loss per Common Share	$ 0.00	$ (0.01)
Weighted-average Number of Shares of Common Stock Outstanding	116,716,036	74,095,036